Published in Eur J Surg Oncol on January 26, 2011
Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol (2013) 0.95
Are primary care providers implementing evidence-based care for breast cancer survivors? Can Fam Physician (2015) 0.93
Options for early breast cancer follow-up in primary and secondary care - a systematic review. BMC Cancer (2012) 0.84
Predicting quality of life after breast cancer surgery using ANN-based models: performance comparison with MR. Support Care Cancer (2012) 0.82
Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up. Ann Surg Oncol (2015) 0.82
Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract (2016) 0.80
Follow-up care for breast cancer survivors: improving patient outcomes. Patient Relat Outcome Meas (2014) 0.79
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review. J Exp Clin Cancer Res (2013) 0.76
Follow-up Reality for Breast Cancer Patients - Standardised Survey of Patients and Physicians and Analysis of Treatment Data. Geburtshilfe Frauenheilkd (2016) 0.75
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey. PLoS One (2014) 0.75
The primary care provider (PCP)-cancer specialist relationship: A systematic review and mixed-methods meta-synthesis. CA Cancer J Clin (2016) 0.75
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg (2005) 3.57
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol (2005) 2.77
Gastric cancer: epidemiology, pathology and treatment. Ann Oncol (2003) 2.53
Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys (2003) 2.38
Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg (2002) 2.13
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg (2009) 2.00
Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry (2002) 1.94
Cosmesis and body image after laparoscopic-assisted and open ileocolic resection for Crohn's disease. Surg Endosc (1998) 1.93
Patient-reported autonomic symptoms in Parkinson disease. Neurology (2007) 1.93
Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol (1993) 1.91
Value of palliative resection in gastric cancer. Br J Surg (2002) 1.90
Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol (2002) 1.78
Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg (2008) 1.75
Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74
Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev (2007) 1.68
Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.59
Neoadjuvant chemotherapy for operable breast cancer. Br J Surg (2007) 1.55
Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
Sentinel lymph node biopsy in breast cancer. Ann Oncol (2002) 1.54
The utility of health states after stroke: a systematic review of the literature. Stroke (2001) 1.51
What is the impact of fecal incontinence on quality of life? Dis Colon Rectum (2001) 1.50
Electron beam therapy is not inferior to superficial x-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys (1995) 1.48
Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg (2009) 1.48
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Origin of presacral local recurrence after rectal cancer treatment. Br J Surg (2010) 1.47
Assessment of cognition in Parkinson's disease. Neurology (2003) 1.45
[Clear-cut beneficial effect of breast cancer screening on the trend in breast-conserving surgery]. Ned Tijdschr Geneeskd (2002) 1.43
[The abdominal compartment syndrome]. Ned Tijdschr Geneeskd (2005) 1.41
Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg (2011) 1.40
Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR (2005) 1.39
Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol (2014) 1.39
[The treatment of patients with gastric carcinoma based on the results of Dutch studies]. Ned Tijdschr Geneeskd (2005) 1.39
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol (2004) 1.39
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat (2013) 1.39
[Ethical aspects of cost considerations in medical decision making]. Ned Tijdschr Geneeskd (1996) 1.38
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer (2005) 1.38
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? Br J Cancer (2001) 1.34
Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat (2013) 1.31
Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer (2004) 1.30
Implicit normativity in evidence-based medicine: a plea for integrated empirical ethics research. Health Care Anal (2003) 1.28
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat (2010) 1.27
Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol (2004) 1.27
Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol (2007) 1.25
Stability of patients' preferences for chemotherapy: the impact of experience. Med Decis Making (2001) 1.21
Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer (2008) 1.21
Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br (2004) 1.21
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry (2004) 1.20
Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol (2010) 1.19
A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider? Eur J Surg Oncol (2010) 1.19
Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Qual Life Res (2000) 1.18
Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol (2010) 1.17
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer (2006) 1.16
Gastric cancers in young and elderly patients show different genomic profiles. J Pathol (2007) 1.14
Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. Br J Cancer (2004) 1.14
Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg (2013) 1.14
A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol (2008) 1.13
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer (2009) 1.08
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. Br J Cancer (2003) 1.08
The Dutch surgical colorectal audit. Eur J Surg Oncol (2013) 1.08
Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother (2004) 1.08
Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol (2005) 1.08
Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. Br J Cancer (2007) 1.08
Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg (2012) 1.08
Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg (2012) 1.06
Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol (2009) 1.05
Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer (2002) 1.05
Treatment of liver metastases of colorectal cancer. Ann Oncol (2005) 1.04
Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer (2010) 1.04
The prognostic role of TGF-β signaling pathway in breast cancer patients. Ann Oncol (2012) 1.04
Near-infrared fluorescence imaging in patients undergoing pancreaticoduodenectomy. Eur Surg Res (2011) 1.03
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer (2006) 1.03
Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol (2010) 1.03
Unstable preferences: a shift in valuation or an effect of the elicitation procedure? Med Decis Making (2000) 1.02
Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg (2007) 1.02
Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice. Colorectal Dis (2007) 1.02
Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer (2013) 1.01
Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia (2006) 1.01
Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg (2005) 1.01
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer (2008) 1.00
Improving quality of cancer care through surgical audit. Eur J Surg Oncol (2010) 1.00
Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer (2013) 0.99
Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer (2003) 0.99
Intelligence of very preterm or very low birthweight infants in young adulthood. Arch Dis Child Fetal Neonatal Ed (2008) 0.98
Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino) (2008) 0.98
The preferred treatment for young women with breast cancer--mastectomy versus breast conservation. Breast (2006) 0.98